本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Royalty Pharma plc

58.93
+0.46000.79%
盤後58.930.00000.00%16:05 EDT
成交量:200.65萬
成交額:1.18億
市值:339.99億
市盈率:31.61
高:59.18
開:58.81
低:58.46
收:58.47
52周最高:64.38
52周最低:34.63
股本:5.77億
流通股本:3.93億
量比:0.73
換手率:0.51%
股息:0.91
股息率:1.54%
每股收益(TTM):1.86
每股收益(LYR):1.78
淨資產收益率:13.97%
總資產收益率:5.09%
市淨率:4.98
市盈率(LYR):33.08

資料載入中...

2026/04/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities